Clinical Trials in Pennsylvania

Showing 9341-9360 of 19,675 trials

Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne

NCT00469755

To determine the efficacy and safety of 12 weeks of treatment with Differin Gel, 0.1% compared to 12 weeks of treatment with Tazorac Cream, 0.1% and compared to 6 weeks treatment with Differin Gel, 0.1% followed by 6 weeks of treatment with Tazorac Cream

Acne Vulgaris

Galderma R&D302 participantsStarted Feb 2006

San Diego, California, United States • Detroit, Michigan, United States • Fridley, Minnesota, United States +9 more locations

COMPLETEDPhase 388 miles

Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis

NCT04124926

To evaluate the efficacy and safety of vonoprazan compared to lansoprazole in participants with erosive esophagitis.

Erosive Esophagitis

Phathom Pharmaceuticals, Inc.1,027 participantsStarted Oct 2019

Anniston, Alabama, United States • Athens, Alabama, United States • Birmingham, Alabama, United States +154 more locations

Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne

Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis

Find Trials by Condition in Pennsylvania

Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients

Interventional Validation of an MDS-Specific Measure of Quality of Life: Assessing the Responsiveness of the Quality of Life in Myelodysplasia Scale (QUALMS-1) to Different Hypomethylating Agent Regimens for Low and Intermediate Risk Disease

A Clinical Assessment Study in X-Linked Myotubular Myopathy (XLMTM) Subjects

LONGEVITY Study. Evaluation of the Device and Battery Longevity of Boston Scientific Market-released ICD and CRT-D Devices

A Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

USCRI READY4Life Program

A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer

Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seronegative Children 6-36 Months

ET-01 in Subjects With Lateral Canthal Lines, LCL-209

Remote Wheelchair Skills Training Efficacy

Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients

Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle

Intratumoral Microdosing of TAK-981 in Head and Neck Cancer

Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients Who Have an Inadequate Response to Eculizumab

Cell-Mediated Immunity Based Primary Prophylaxis for CMV Infection in Organ Transplant Recipients

Efficacy and Safety of Orally Administered DS102 in Patients With Acute Alcoholic Hepatitis

Tissue Collection for Correlation Between ATM Alterations by Next-Generation Sequencing and ATM Loss-of-Protein

Prone Positioning Short-term Effects on Tissue Oxygen Saturation in Critical COVID-19 Patients